在阿尔茨海默病中,一个客观而敏感的电生理学标记是词语语义分类障碍
Justine David1, Lisa Quenon2, Bernard Hanseeuw2
1Université de Lorraine, CNRS, IMoPA, 29 Avenue du Maréchal de Lattre de Tassigny, F-54000 Nancy, France.
概括
使用快速周期视觉刺激 (FPVS-EEG) 的脑电图为检测阿尔茨海默病 (AD) 中的语义分类缺陷提供了快速,客观的测量方法. 这种方法显示,与健康对照人群相比,阿兹海默症患者的大脑反应显著减少.
科学领域:
- 神经科学是一个神经科学.
- 认知科学 认知科学
- 医疗成像医学成像
背景情况:
- 阿尔茨海默病 (AD) 的特点是认知能力下降,包括语义处理中的障碍.
- 客观和敏感的生物标志物对于早期的阿尔茨海默病诊断和监测疾病进展至关重要.
研究的目的:
- 开发和验证一种使用脑电图 (EEG) 和快速周期视觉刺激 (FPVS) 的电生理学测量方法,以评估AD的语义词类分类障碍.
- 建立FPVS-EEG作为一个敏感和客观的工具,以区分AD患者与健康对照.
主要方法:
- 一组25名阿尔茨海默病患者和25名年龄匹配的健康对照在经过验证的FPVS范式期间接受了EEG记录.
- 参与者看到了从一个语义类别 (城市) 的快速呈现的单词 (4 Hz),与来自另一个类别 (动物,1 Hz) 的单词相交.
- 在频率域中分析了EEG数据,以确定特定波频率的脑反应.
主要成果:
- 健康对照对象在左侧角及角皮层上表现出强大的EEG响应在1Hz波,表明自动语义分类.
- 阿尔茨海默病患者的反应显著减少 (对照组不到25%),与大脑脊髓液Tau蛋白水平相反相关.
- 只需2.5分钟的测试就能实现显著的群体差异,特别是当包括左侧中央EEG区域时.
结论:
- 根据语义分类能力,FPVS-EEG能够快速客观地将阿尔茨海默病患者与健康对照者区分开来.
- 这种技术为AD的语义处理缺陷提供了有价值的电生理指数,有望用于临床应用.
更多相关视频
06:48Lexical Decision Task for Studying Written Word Recognition in Adults with and without Dementia or Mild Cognitive Impairment
Published on: June 25, 2019
9.1K
08:17A Semantic Priming Event-related Potential ERP Task to Study Lexico-semantic and Visuo-semantic Processing in Autism Spectrum Disorder
Published on: April 12, 2018
10.5K
相关概念视频
01:26Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
01:22Alzheimer's Disease: Treatment
162
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
162
01:30Dementia
94
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
94